BNP Paribas Financial Markets Raises Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

BNP Paribas Financial Markets increased its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 21.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 344,500 shares of the medical device company's stock after buying an additional 60,979 shares during the period. BNP Paribas Financial Markets owned about 0.17% of Cooper Companies worth $31,670,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Wahed Invest LLC raised its position in shares of Cooper Companies by 4.1% in the 4th quarter. Wahed Invest LLC now owns 4,933 shares of the medical device company's stock valued at $453,000 after purchasing an additional 195 shares during the last quarter. Comerica Bank grew its stake in shares of Cooper Companies by 7.8% during the 4th quarter. Comerica Bank now owns 77,559 shares of the medical device company's stock worth $7,130,000 after purchasing an additional 5,611 shares during the period. Soros Fund Management LLC increased its holdings in Cooper Companies by 29.1% in the fourth quarter. Soros Fund Management LLC now owns 225,930 shares of the medical device company's stock valued at $20,770,000 after buying an additional 50,930 shares in the last quarter. AQR Capital Management LLC increased its stake in shares of Cooper Companies by 4.2% in the 4th quarter. AQR Capital Management LLC now owns 245,885 shares of the medical device company's stock valued at $22,604,000 after purchasing an additional 9,894 shares in the last quarter. Finally, Lido Advisors LLC raised its stake in shares of Cooper Companies by 14.2% during the 4th quarter. Lido Advisors LLC now owns 3,364 shares of the medical device company's stock worth $309,000 after buying an additional 419 shares during the period. 24.39% of the stock is owned by institutional investors.

Cooper Companies Stock Down 0.8 %

COO stock traded down $0.65 during trading on Friday, hitting $82.27. 1,265,544 shares of the company's stock were exchanged, compared to its average volume of 1,447,855. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 52-week low of $69.81 and a 52-week high of $112.38. The business has a 50-day moving average price of $80.54 and a two-hundred day moving average price of $90.81. The stock has a market capitalization of $16.45 billion, a price-to-earnings ratio of 42.19, a PEG ratio of 2.25 and a beta of 1.08.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. The business had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. As a group, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Ratings Changes

A number of analysts have recently issued reports on COO shares. Citigroup lowered their price target on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Piper Sandler reissued an "overweight" rating and issued a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Robert W. Baird reduced their price objective on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a report on Friday, March 7th. Stifel Nicolaus decreased their price target on Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Finally, BNP Paribas raised shares of Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Cooper Companies currently has an average rating of "Moderate Buy" and an average target price of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.